BACKGROUND: Ketamine elicits rapid onset antidepressant effects in patients with clinical depression through mechanisms hypothesized to involve the genesis of neocortical dendritic spines and synapses. Yet, the observed changes in dendritic spine morphology usually emerge well after ketamine clearance, raising questions about the link between rapid behavioral effects of ketamine and plasticity. METHODS: Here, we used two-photon glutamate uncaging/imaging to focally induce spinogenesis in the medial prefrontal cortex, directly interrogating baseline and ketamine-associated plasticity of deep layer pyramidal neurons in C57BL/6 mice. We combined pharmacological, genetic, optogenetic, and chemogenetic manipulations to interrogate dopaminergic mechanisms underlying ketamine-induced rapid enhancement in evoked plasticity and associated behavioral changes. RESULTS: We found that ketamine rapidly enhances glutamate-evoked spinogenesis in the medial prefrontal cortex, with timing that matches the onset of its behavioral efficacy and precedes changes in dendritic spine density. Ketamine increases evoked cortical spinogenesis through dopamine Drd1 receptor (Drd1) activation that requires dopamine release, compensating blunted plasticity in a learned helplessness paradigm. The enhancement in evoked spinogenesis after Drd1 activation or ketamine treatment depends on postsynaptic protein kinase A activity. Furthermore, ketamine's behavioral effects are blocked by chemogenetic inhibition of dopamine release and mimicked by activating presynaptic dopaminergic terminals or postsynaptic Gαs-coupled cascades in the medial prefrontal cortex. CONCLUSIONS: Our findings highlight dopaminergic mediation of rapid enhancement in activity-dependent dendritic spinogenesis and behavioral effects induced by ketamine.
BACKGROUND: Ketamine elicits rapid onset antidepressant effects in patients with clinical depression through mechanisms hypothesized to involve the genesis of neocortical dendritic spines and synapses. Yet, the observed changes in dendritic spine morphology usually emerge well after ketamine clearance, raising questions about the link between rapid behavioral effects of ketamine and plasticity. METHODS: Here, we used two-photon glutamate uncaging/imaging to focally induce spinogenesis in the medial prefrontal cortex, directly interrogating baseline and ketamine-associated plasticity of deep layer pyramidal neurons in C57BL/6 mice. We combined pharmacological, genetic, optogenetic, and chemogenetic manipulations to interrogate dopaminergic mechanisms underlying ketamine-induced rapid enhancement in evoked plasticity and associated behavioral changes. RESULTS: We found that ketamine rapidly enhances glutamate-evoked spinogenesis in the medial prefrontal cortex, with timing that matches the onset of its behavioral efficacy and precedes changes in dendritic spine density. Ketamine increases evoked cortical spinogenesis through dopamine Drd1 receptor (Drd1) activation that requires dopamine release, compensating blunted plasticity in a learned helplessness paradigm. The enhancement in evoked spinogenesis after Drd1 activation or ketamine treatment depends on postsynaptic protein kinase A activity. Furthermore, ketamine's behavioral effects are blocked by chemogenetic inhibition of dopamine release and mimicked by activating presynaptic dopaminergic terminals or postsynaptic Gαs-coupled cascades in the medial prefrontal cortex. CONCLUSIONS: Our findings highlight dopaminergic mediation of rapid enhancement in activity-dependent dendritic spinogenesis and behavioral effects induced by ketamine.
Authors: Arpiar Saunders; Evan Z Macosko; Alec Wysoker; Melissa Goldman; Fenna M Krienen; Heather de Rivera; Elizabeth Bien; Matthew Baum; Laura Bortolin; Shuyu Wang; Aleksandrina Goeva; James Nemesh; Nolan Kamitaki; Sara Brumbaugh; David Kulp; Steven A McCarroll Journal: Cell Date: 2018-08-09 Impact factor: 41.582
Authors: Ella J Daly; Jaskaran B Singh; Maggie Fedgchin; Kimberly Cooper; Pilar Lim; Richard C Shelton; Michael E Thase; Andrew Winokur; Luc Van Nueten; Husseini Manji; Wayne C Drevets Journal: JAMA Psychiatry Date: 2018-02-01 Impact factor: 21.596
Authors: Antoine Rogeau; Giovanna Nordio; Mattia Veronese; Kirsten Brown; Matthew M Nour; Martin Osugo; Sameer Jauhar; Oliver D Howes; Robert A McCutcheon Journal: Mol Psychiatry Date: 2022-05-11 Impact factor: 15.992
Authors: Scott R Burlingham; Nicole F Wong; Lindsay Peterkin; Lily Lubow; Carolina Dos Santos Passos; Orion Benner; Michael Ghebrial; Thomas P Cast; Matthew A Xu-Friedman; Thomas C Südhof; Soham Chanda Journal: Nat Commun Date: 2022-06-01 Impact factor: 17.694
Authors: Jokubas Ausra; Mingzheng Wu; Xin Zhang; Abraham Vázquez-Guardado; Patrick Skelton; Roberto Peralta; Raudel Avila; Thomas Murickan; Chad R Haney; Yonggang Huang; John A Rogers; Yevgenia Kozorovitskiy; Philipp Gutruf Journal: Proc Natl Acad Sci U S A Date: 2021-07-27 Impact factor: 11.205
Authors: Ling-Xiao Shao; Clara Liao; Ian Gregg; Pasha A Davoudian; Neil K Savalia; Kristina Delagarza; Alex C Kwan Journal: Neuron Date: 2021-07-05 Impact factor: 18.688
Authors: Quansan Yang; Tong Wei; Rose T Yin; Mingzheng Wu; Yameng Xu; Jahyun Koo; Yeon Sik Choi; Zhaoqian Xie; Sheena W Chen; Irawati Kandela; Shenglian Yao; Yujun Deng; Raudel Avila; Tzu-Li Liu; Wubin Bai; Yiyuan Yang; Mengdi Han; Qihui Zhang; Chad R Haney; K Benjamin Lee; Kedar Aras; Tong Wang; Min-Ho Seo; Haiwen Luan; Seung Min Lee; Anlil Brikha; Nayereh Ghoreishi-Haack; Lori Tran; Iwona Stepien; Fraser Aird; Emily A Waters; Xinge Yu; Anthony Banks; Gregory D Trachiotis; John M Torkelson; Yonggang Huang; Yevgenia Kozorovitskiy; Igor R Efimov; John A Rogers Journal: Nat Mater Date: 2021-07-29 Impact factor: 43.841